Wells, J. A., Glassman, A. R., Ayala, A. R., Jampol, L. M., Bressler, N. M., Bressler, S. B., . . . Beck, R. W. (2016). Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial. Ophthalmology.
Citação norma ChicagoWells, John A., et al. "Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results From a Comparative Effectiveness Randomized Clinical Trial." Ophthalmology 2016.
MLA citiranjeWells, John A., et al. "Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results From a Comparative Effectiveness Randomized Clinical Trial." Ophthalmology 2016.
Opozorilo: Ti citati niso vedno 100% točni.